Cubist Systematic Strategies’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-250,889
| Closed | -$3.95M | – | 4280 |
|
|
2024
Q1 | $3.95M | Sell |
250,889
-27,496
| -10% | -$423K | 0.02% | 1121 |
|
|
2023
Q4 | $4.49M | Buy |
278,385
+58,761
| +27% | +$750K | 0.03% | 934 |
|
|
2023
Q3 | $2.79M | Buy |
+219,624
| New | +$3.03M | 0.02% | 1126 |
|
|
2023
Q2 | – | Sell |
-123,486
| Closed | -$1.91M | – | 4486 |
|
|
2023
Q1 | $1.91M | Sell |
123,486
-11,676
| -9% | -$195K | 0.01% | 1705 |
|
|
2022
Q4 | $2.22M | Sell |
135,162
-181,551
| -57% | -$2.95M | 0.01% | 1774 |
|
|
2022
Q3 | $5.86M | Buy |
316,713
+136,570
| +76% | +$2.14M | 0.03% | 922 |
|
|
2022
Q2 | $2.37M | Buy |
180,143
+45,904
| +34% | +$507K | 0.01% | 1686 |
|
|
2022
Q1 | $1.24M | Sell |
134,239
-17,792
| -12% | -$151K | 0.01% | 1864 |
|
|
2021
Q4 | $1.49M | Buy |
152,031
+127,176
| +512% | +$2.39M | 0.01% | 1624 |
|
|
2021
Q3 | $845K | Buy |
24,855
+24,717
| +17,911% | +$789K | 0.01% | 1657 |
|
|
2021
Q2 | $5K | Sell |
138
-7,197
| -98% | -$279K | ﹤0.01% | 2877 |
|
|
2021
Q1 | $329K | Sell |
7,335
-14,369
| -66% | -$669K | ﹤0.01% | 2200 |
|
|
2020
Q4 | $1.24M | Buy |
21,704
+7,852
| +57% | +$465K | 0.02% | 1238 |
|
|
2020
Q3 | $711K | Buy |
13,852
+10,052
| +265% | +$492K | 0.01% | 1535 |
|
|
2020
Q2 | $227K | Sell |
3,800
-14,446
| -79% | -$773K | ﹤0.01% | 1977 |
|
|
2020
Q1 | $751K | Sell |
18,246
-62,705
| -77% | -$3.48M | 0.02% | 1009 |
|
|
2019
Q4 | $5.04M | Buy |
80,951
+79,751
| +6,646% | +$3.79M | 0.09% | 309 |
|
|
2019
Q3 | $41K | Sell |
1,200
-12,363
| -91% | -$366K | ﹤0.01% | 2076 |
|
|
2019
Q2 | $306K | Buy |
13,563
+4,854
| +56% | +$114K | 0.01% | 1788 |
|
|
2019
Q1 | $202K | Sell |
8,709
-12,364
| -59% | -$324K | 0.01% | 1778 |
|
|
2018
Q4 | $442K | Buy |
+21,073
| New | +$518K | 0.02% | 1048 |
|
Other funds holding DCPH
Cubist Systematic Strategies's DCPH Position: Q2 2024 in Review
Cubist Systematic Strategies sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 250,889 shares — an estimated $3.95M sold.
Cubist Systematic Strategies first reported a position in DCPH in Q4 2018 and held it in 21 quarters. The position peaked at $5.86M in Q3 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Cubist Systematic Strategies reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Cubist Systematic Strategies sold 250,889 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $3.95M.
- Cubist Systematic Strategies first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 21 quarters.
- Cubist Systematic Strategies's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $5.86M in Q3 2022.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.